Mutations in
mig-10 cause incomplete embryonic migration of neurons CAN, ALM and HSN as well as shortened posterior excretory canals. To define more precisely the role of
mig-10 in C. elegans development, we have begun a molecular characterization. We have identified
mig-10 coding sequence by transformation rescue of mutant phenotypes and DNA sequencing of
ct41 (amber) and
e2527 (TTTCAA splice acceptor) mutant alleles. Genomic sequencing by us and the genome consortium (1) initially predicted a MIG-10 product of 650aa's containing a large region (~300 aa's) of similarity with a recently identified family of mammalian SH2 domain proteins, Grb7 and Grb10 (2,3). We call this region of similarity the GM domain (for Grb and Mig). The precise functions of Grb7 and Grb10 are not known, but current evidence supports a role in signal transduction: Grb7 is overexpressed in certain breast cancers where it is bound to the growth factor receptor HER2 (4), while Grb10 can interact with the insulin receptor (5). By sequencing cDNA clones and RT-PCR products, we have identified two SL1-trans-spliced
mig-10 transcripts which contain different first exons. One transcript can encode the predicted 650aa MIG-10 product, the other a 667aa isoform. Neither predicted MIG-10 protein contains an SH2 domain, but both share with Grb7 and Grb10 the GM domain, a pleckstrin homology (PH) domain (within the GM domain) and proline-rich sequences. The PH domain is commonly found in signal transduction and cytoskeletal proteins, although its function remains controversial (6). Pro-rich sequences like those found in MIG-10 can bind SH3 domains found in many signaling and cytoskeletal proteins (6). Our mosaic analysis reveals that
mig-10 acts cell nonautonomously during development of the excretory canals and suggests a possible focus within descendants of the AB lineage, possibly epidermis. We hypothesize that
mig-10 may function in signal transduction and/or cytoskeletal organization outside of motile cells. We are currently undertaking additional experiments to clarify the role of
mig-10, including immunolocalization of MIG-10 proteins. 1. Wilson, R. et al. 1994. Nature 368: 32-38. 2. Margolis, B. et al. 1992. Proc. Natl. Acad. Sci. 89: 8894-8898. 3. Ooi, J. et al. 1995. Oncogene 10: 1621-1630. 4. Stein, D. et al. 1994. EMBO J. 13: 1331-1340. 5. Hansen, H. et al. 1996. J. Biol. Chem. 271: 8882-8886. 6. Pawson, T. 1995. Nature 373: 573-580.